1. Home
  2. RTO vs JAZZ Comparison

RTO vs JAZZ Comparison

Compare RTO & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

HOLD

Current Price

$30.61

Market Cap

16.6B

ML Signal

HOLD

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$232.52

Market Cap

15.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RTO
JAZZ
Founded
1925
2003
Country
United Kingdom
Ireland
Employees
64084
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.6B
15.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
RTO
JAZZ
Price
$30.61
$232.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
14
Target Price
$35.00
$217.57
AVG Volume (30 Days)
871.7K
810.7K
Earning Date
03-09-2026
05-05-2026
Dividend Yield
1.60%
N/A
EPS Growth
N/A
N/A
EPS
N/A
4.43
Revenue
N/A
$1,618,693,000.00
Revenue This Year
$17.05
$6.22
Revenue Next Year
$4.35
$7.68
P/E Ratio
$222.16
$53.20
Revenue Growth
N/A
N/A
52 Week Low
$22.72
$105.00
52 Week High
$34.67
$243.32

Technical Indicators

Market Signals
Indicator
RTO
JAZZ
Relative Strength Index (RSI) 46.02 54.77
Support Level $30.30 $224.23
Resistance Level $32.12 $242.66
Average True Range (ATR) 0.44 7.12
MACD 0.11 -1.58
Stochastic Oscillator 55.64 48.45

Price Performance

Historical Comparison
RTO
JAZZ

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: